Characterization of Endocarditis to Streptococci and Impact of the CMI on the Future of the Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03306225

Enrollment

414

Registered

2017-10-10

Start date

2016-07-08

Completion date

2019-12-31

Last updated

2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endocarditis, Bacterial

Brief summary

The infectious endocarditis is a grave infection the incidence of which is at present esteemed at 30-100 episodes by million inhabitants a year. This infection is marked with a heavy morbi-mortality.Preliminary studies seem to show an abnormally high death rate at the patients presenting an infectious endocarditis to streptococci with an inhibitive minimal concentration raised to the amoxicilline. The aim of the study is to describe the epidemiology and the clinical presentations of the patients presenting an endocarditis to streptococci

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age \> 18 years * endocartitis with steptococci with Duke's criteria

Exclusion criteria

* age \< 18 years * suspiscious endocarditis without Duke's criteria

Design outcomes

Primary

Measure	Time frame
Evaluation of factors associated to the mortality in the patients presenting an endocarditis to streptococci.	an average of one year

Countries

France

Outcome results